Skip to main content
. 2013 Aug 16;30(10):1333–1339. doi: 10.1007/s10815-013-0070-6

Table 2.

All Ages

aCGH
Cycles = 39
Patients = 35
No aCGH
Cycles = 394
Patients = 311
IR [95 % CI]
p-value
aCGH
Cycles = 39
Patients = 35
No aCGH
Cycles = 394
Patients = 311
RRb/IRRc [95 % CI]
p-value
Age 37.3 (3.4) 35.4 (4.3) 1.9 [0.6 – 3.1]
p = 0.0036
Implantation rate 30/57 (52.63 %) 253/1321 (19.15 %) IRR = 2.66 [2.08–3.40]
p < 0.0001
FSHa 6.1 (2.0) 5.9 (2.4) 0.2 [−0.7–1.1]
p = 0.6929
Clinical pregnancy rate 27/39 (69.23 %) 173/394 (43.91 %) RR = 1.58 [1.24–1.99]
p = 0.0002
AMHa 2.8 (2.4) 3.3 (3.2) −0.5 [−1.9.0–0.9]
p = 0.4619
Ongoing pregnancy rate 24/39 (61.54 %) 128/394 (32.49 %) RR = 1.91 [1.42–2.55]
p < 0.0001
# oocytes fertilized 9.1 (4.9) 8.5 (3.1) 0.5 [−1.2 – 2.3]
p = 0.5351
Miscarriage rate 3/27 (11.11 %) 45/173 (26.01 %) RR = 0.43 [0.14–1.29]
p = 0.1305
# embryos transferred 1.5 (0.9) 3.3 (1.4) −1.8 [−2.2 – −1.3]
p = <0.0001
Multiple pregnancy rate 2/24 (8.33 %) 44/128 (34.38 %) RR = 0.17 [0.04–0.63]
p = 0.0082

a The mixed model with a repeated statement would not converge so the mean FSH/AMH from all cycles for each patient was computed and used as the outcome measure and independence was assumed among means for estimates presented

b Relative Risk (RR) estimates used to compare probabilities

c Incidence Rate Ratio (IRR) estimates used to compare rates